Cargando…

Lipidomics unveils the complexity of the lipidome in metabolic diseases

Dysregulation of lipid metabolism is responsible for pathologies of human diseases including metabolic diseases. Recent advances in lipidomics analysis allow for the targeted and untargeted identification of lipid species and for their quantification in normal and diseased conditions. Herein, this r...

Descripción completa

Detalles Bibliográficos
Autores principales: Lydic, Todd A., Goo, Young-Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786598/
https://www.ncbi.nlm.nih.gov/pubmed/29374337
http://dx.doi.org/10.1186/s40169-018-0182-9
_version_ 1783295806725423104
author Lydic, Todd A.
Goo, Young-Hwa
author_facet Lydic, Todd A.
Goo, Young-Hwa
author_sort Lydic, Todd A.
collection PubMed
description Dysregulation of lipid metabolism is responsible for pathologies of human diseases including metabolic diseases. Recent advances in lipidomics analysis allow for the targeted and untargeted identification of lipid species and for their quantification in normal and diseased conditions. Herein, this review provides a brief introduction to lipidomics, highlights its application to characterize the lipidome at the cellular and physiological levels under different biological conditions, and discusses the potential for the use of lipidomics in the discovery of biomarkers.
format Online
Article
Text
id pubmed-5786598
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-57865982018-02-05 Lipidomics unveils the complexity of the lipidome in metabolic diseases Lydic, Todd A. Goo, Young-Hwa Clin Transl Med Review Dysregulation of lipid metabolism is responsible for pathologies of human diseases including metabolic diseases. Recent advances in lipidomics analysis allow for the targeted and untargeted identification of lipid species and for their quantification in normal and diseased conditions. Herein, this review provides a brief introduction to lipidomics, highlights its application to characterize the lipidome at the cellular and physiological levels under different biological conditions, and discusses the potential for the use of lipidomics in the discovery of biomarkers. Springer Berlin Heidelberg 2018-01-26 /pmc/articles/PMC5786598/ /pubmed/29374337 http://dx.doi.org/10.1186/s40169-018-0182-9 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Lydic, Todd A.
Goo, Young-Hwa
Lipidomics unveils the complexity of the lipidome in metabolic diseases
title Lipidomics unveils the complexity of the lipidome in metabolic diseases
title_full Lipidomics unveils the complexity of the lipidome in metabolic diseases
title_fullStr Lipidomics unveils the complexity of the lipidome in metabolic diseases
title_full_unstemmed Lipidomics unveils the complexity of the lipidome in metabolic diseases
title_short Lipidomics unveils the complexity of the lipidome in metabolic diseases
title_sort lipidomics unveils the complexity of the lipidome in metabolic diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786598/
https://www.ncbi.nlm.nih.gov/pubmed/29374337
http://dx.doi.org/10.1186/s40169-018-0182-9
work_keys_str_mv AT lydictodda lipidomicsunveilsthecomplexityofthelipidomeinmetabolicdiseases
AT gooyounghwa lipidomicsunveilsthecomplexityofthelipidomeinmetabolicdiseases